Further prospective cohort studies with bigger sample size and limited duration of HU and IM are needed to prove the role of BCR-ABL/ABL ratio, MDA, HIF-1α, and P-gp on MMR achievement in chronic phase CML patient. Here, HIF1A is linked to chronic myelogenous leukemia, BCR-ABL1 positive.